KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?
about
Application of proteomics in the study of tumor metastasis.Management of gastrointestinal stromal tumors.Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome.Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)
P2860
KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
KIT gene mutations in gastroin ...... ex than previously recognized?
@en
KIT gene mutations in gastroin ...... ex than previously recognized?
@nl
type
label
KIT gene mutations in gastroin ...... ex than previously recognized?
@en
KIT gene mutations in gastroin ...... ex than previously recognized?
@nl
prefLabel
KIT gene mutations in gastroin ...... ex than previously recognized?
@en
KIT gene mutations in gastroin ...... ex than previously recognized?
@nl
P2093
P2860
P1476
KIT gene mutations in gastroin ...... ex than previously recognized?
@en
P2093
Brian P Rubin
Christopher D M Fletcher
Christopher L Corless
Jonathan A Fletcher
Leonie K Ashman
Michael C Heinrich
P2860
P304
737-8; author reply 738-9
P356
10.1016/S0002-9440(10)64229-0
P407
P577
2002-08-01T00:00:00Z